hk-ipo/data/extracted_text/06938/allotment_results_2026-01-08_2026010801352.txt

--- page 1 ---
1
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock Exchange ”)
and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no responsibility for the contents of this
announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability
whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this
announcement.
This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States
(including its territories and possessions, any state of the United States and the District of Columbia). This
announcement does not, and is not intended to, constitute or form a part of any offer or solicitation to purchase or
subscribe for securities in the United States or in any other jurisdiction. The Offer Shares have not been and will not be
registered under the United States Securities Act of 1933, as amended from time to time (the “U.S. Securities Act ”) or
securities law of any state or other jurisdiction of the United States and may not be offered, sold, pledged or otherwise
transferred within the United States, except in transactions exempt from, or not subject to, the registration requirements
of the U.S. Securities Act and in compliance with any applicable state securities laws. There will be no public offer of
the Offer Shares in the United States. The Offer Shares are being offered and sold solely (1) to qualified institutional
buyers as defined in Rule 144A under the U.S. Securities Act pursuant to an exemption from registration under the U.S.
Securities Act; and (2) outside the United States in offshore transactions in reliance on Regulation S under the U.S.
Securities Act and applicable laws of each jurisdiction where those offers and sales occur.
This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase
or subscribe for securities. This announcement is not a prospectus. Potential investors should read the prospectus dated
December 31, 2025 (the “Prospectus ”) issued by Suzhou Ribo Life Science Co., Ltd. (ʮ
̡) (the “Company ”) for detailed information about the Global Offering described below before deciding whether or
not to invest in the H Shares thereby being offered. The Company has not been and will not be registered under the U.S.
Investment Company Act of 1940, as amended.
Unless otherwise defined in this announcement, capitalized terms used herein shall have the same meanings as those
defined in the Prospectus.
In connection with the Global Offering, China International Capital Corporation Hong Kong Securities Limited
as stabilizing manager (the “Stabilizing Manager ”) (or its affiliates or any person acting for it) on behalf of the
Underwriters, to the extent permitted by the applicable laws and regulatory requirements of Hong Kong or elsewhere,
may make purchases, over-allocate or effect transactions in the market or otherwise take such stabilizing action(s) with
a view to stabilizing or supporting the market price of the H Shares at a level higher than that which might otherwise
prevail for a limited period after the Listing Date. However, there is no obligation on the Stabilizing Manager (or its
affiliates or any person acting for it) to conduct any such stabilizing action. Such stabilizing action, if taken, (a) will
be conducted at the absolute discretion of the Stabilizing Manager (or its affiliates or any person acting for it) and in
what the Stabilizing Manager reasonably regards as the best interest of the Company, (b) may be discontinued at any
time and (c) is required to be brought to an end within 30 days after the last day for lodging applications under the
Hong Kong Public Offering.
Potential investors should note that no stabilizing action can be taken to support the price of the H Shares for longer
than the stabilization period, which will begin on the Listing Date and is expected to expire on Thursday, February
5, 2026, being the 30th day after the last day for lodging applications under the Hong Kong Public Offering. After
this date, when no further stabilizing action may be taken, demand for the H Shares, and therefore the price of the H
Shares, could fall.
The obligations of the Hong Kong Underwriters under the Hong Kong Underwriting Agreement to subscribe for, and
to procure subscribers for, the Hong Kong Offer Shares, are subject to termination by the Overall Coordinators (for
themselves and on behalf of the Underwriters) if certain events shall occur prior to 8:00 a.m. on the Listing Date. Such
grounds are set out in the section headed “Underwriting ” in the Prospectus. It is important that you refer to that section
for further details.


--- page 2 ---
2
Suzhou Ribo Life Science Co., Ltd.
ʮ̡
(A joint stock company incorporated in the People ’s Republic of China with limited liability)
GLOBAL OFFERING
Number of Offer Shares under
the Global Offering
: 31,610,400 H Shares (taking into account
 the full exercise of the Offer Size
 Adjustment Option and subject to
 the Over-allotment Option)
Number of Hong Kong Offer Shares : 2,748,800 H Shares
Number of International Offer Shares : 28,861,600 H Shares (taking into account
 the full exercise of the Offer Size
 Adjustment Option and subject to
 the Over-allotment Option)
Offer Price : HK$57.97 per Offer Share, plus brokerage
 of 1.0%, SFC transaction levy of
 0.0027%, AFRC transaction levy
 of 0.00015% and Hong Kong Stock
 Exchange trading fee of 0.00565%
Nominal value : RMB1.00 per H Share
Stock code : 6938
Joint Sponsors, Overall Coordinators, Joint Global Coordinators, Joint Bookrunners,
Joint Lead Managers
Overall Coordinators, Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers
Joint Global Coordinator, Joint Bookrunner, Joint Lead Manager
Joint Bookrunner, Joint Lead Manager


--- page 3 ---
3
SUZHOU RIBO LIFE SCIENCE CO., LTD.
ʮ̡
ANNOUNCEMENT OF ALLOTMENT RESULTS
Unless otherwise defined herein, capitalized terms used in this announcement shall have the same
meanings as those defined in the prospectus dated December 31, 2025 (the “Prospectus ”) issued
by Suzhou Ribo Life Science Co., Ltd. (ʮ̡ ) (the “Company ”).
Warning: In view of high concentration of shareholding in a small number of Shareholders,
Shareholders and prospective investors should be aware that the price of the H Shares
could move substantially even with a small number of H Shares traded and should exercise
extreme caution when dealing in the H Shares.
SUMMARY
Company information
Stock code 6938
Stock short name RIBOLIFE-B
Dealings commencement date January 9, 2026*
* see note at the end of the announcement
Price Information
Fixed Offer Price HK$57.97
Offer Shares and Share Capital
Number of Offer Shares 31,610,400 H Shares
Final Number of Offer Shares in Hong Kong Public
 Offering
2,748,800 H Shares
Final Number of Offer Shares in International Offering
 (taking into account the full exercise of the Offer Size
 Adjustment Option and subject to the Over-allotment
 Option)
28,861,600 H Shares
Number of issued shares upon Listing (before any exercise
 of the Over-allotment Option)
165,813,510 Shares
The number of Offer Shares above is determined after taking into account the additional shares
issued under the following Offer Size Adjustment Option.


--- page 4 ---
4
Offer Size Adjustment Option (Upsize option)
Number of additional shares issued under the option 4,123,000 H Shares
 – International Offering 4,123,000 H Shares
Over-allocation
No. of Offer Shares over-allocated 4,741,400 H Shares
 – International Offering 4,741,400 H Shares
Such over-allocation may be covered by exercising the Over-allotment Option or by making
purchases in the secondary market at prices that do not exceed the Offer Price or a combination
of these means. In the event the Over-allotment Option is exercised, an announcement will be
made on the Stock Exchange ’s website.
Proceeds
Gross proceeds (Note) HK$1,832.45 million
Less: Estimated listing expenses payable based on the
 Offer Price
HK$130.65 million
Net proceeds HK$1,701.80 million
Note: Gross proceeds refer to the amount to which the issuer is entitled to receive. For details of the use of
proceeds, please refer to the Prospectus dated December 31, 2025.
ALLOTMENT RESULTS DETAILS
HONG KONG PUBLIC OFFERING
No. of valid applications 42,771
No. of successful applications 5,367
Subscription level 101.06 times
Claw-back triggered N/A
No. of Offer Shares initially available under the
 Hong Kong Public Offering
2,748,800 H Shares
No. of Offer Shares reallocated from the International
 Offering (claw-back)
0
Final no. of Offer Shares under the Hong Kong
 Public Offering
2,748,800 H Shares
% of Offer Shares under the Hong Kong Public
 Offering to the Global Offering
8.7%
Note: For details of the final allocation of shares to the Hong Kong Public Offering, investors can
refer to https://www.eipo.com.hk/eIPOAllotment to perform a search by identification number or
https://www.eipo.com.hk/eIPOAllotment for the full list of allottees.


--- page 5 ---
5
INTERNATIONAL OFFERING
No. of placees 177
Subscription Level 16.7 times
No. of Offer Shares initially available under the
 International Offering
24,738,600 H Shares
No. of Offer Shares reallocated to the Hong Kong
 Public Offering (claw-back)
0
Final no. of Offer Shares under the International
 Offering (taking into account the full exercise of
 the Offer Size Adjustment Option)
28,861,600 H Shares
% of Offer Shares under the International Offering
 to the Global Offering
91.3%
The Directors confirm that, to the best of their knowledge, information and belief, save for a
consent under paragraph 1C(2) of Appendix F1 to the Listing Rules (the “Placing Guidelines ”)
granted by the Stock Exchange to permit the Company to allocate certain Offer Shares in the
International Offering to close associates of existing Shareholders of the Company, (i) none of the
Offer Shares subscribed by the placees and the public have been financed directly or indirectly
by the Company, any of the Directors, chief executive of the Company, Supervisors, substantial
Shareholders, existing Shareholders of the Company or any of its subsidiaries or their respective
close associates; and (ii) none of the placees and the public who have purchased the Offer Shares
are accustomed to taking instructions from the Company, any of the Directors, chief executive
of the Company, Supervisors, controlling Shareholders, substantial Shareholders, existing
Shareholders of the Company or any of its subsidiaries or their respective close associates in
relation to the acquisition, disposal, voting or other disposition of Shares registered in his/her/its
name or otherwise held by him/her/it.
Erik Selin Fastigheter Aktiebolag ( “Erik Selin Fastigheter AB ”) is a substantial shareholder
of Ribocure AB, a subsidiary of the Company. Therefore, Erik Selin Fastigheter AB is a core
connected person of the Company. The Company has applied for, and the Stock Exchange has
granted, a waiver from strict compliance with Rule 9.09(b) of the Listing Rules to permit Erik
Selin Fastigheter AB to participate as a cornerstone investor in the Global Offering. For details,
please refer to the section headed “Waiver From Strict Compliance with the Listing Rules
and Exemption From Strict Compliance with the Companies (Winding Up and Miscellaneous
Provisions) Ordinance – Waiver From Strict Compliance with Rule 9.09(b) of the Listing Rules in
relation to Cornerstone Subscription by a Core Connected Person ” in the Prospectus.


--- page 6 ---
6
The placees in the International Offering include the following:
Cornerstone Investors
Investor (1)
Number
of Offer
Shares
allocated
% of Offer
Shares (2)
% of total
issued H
Shares
after the
Global
Offering (2)
% of total
issued
share
capital
after the
Global
Offering (2)
Existing
shareholders
or their close
associates
Arc Avenue Asset Management Pte. Ltd. 671,000 2.1% 0.4% 0.4% No
Bright Stone Holdings Limited 536,800 1.7% 0.3% 0.3% No
China Asset Management Co., Ltd. 2,013,200 6.4% 1.2% 1.2% No
Da Cheng International Asset
Management Company Limited and
Dacheng Fund Management Company
Limited
2,013,200 6.4% 1.2% 1.2% No
Erik Selin Fastigheter Aktiebolag 1,342,000 4.2% 0.8% 0.8% No(3)
Himension Fund 1,342,000 4.2% 0.8% 0.8% No
IvyRock Asset Management (HK)
Limited
536,800 1.7% 0.3% 0.3% No
Mingxin Growth Ventures LS2 Limited 1,342,000 4.2% 0.8% 0.8% No
Springs Capital (Hong Kong) Limited 1,342,000 4.2% 0.8% 0.8% No
Taikang Life Insurance Co., Ltd. 1,610,400 5.1% 1.0% 1.0% No
Tenbagger Capital Nengxin), LP. (ܽ
၍ଣΥྫΆุ (ࠢ
Υྫ)), Tenbagger Capital (Shanghai,
Ziran), LP. (Ԏҳ༟၍ଣΥ
ྫΆุ(Υྫ )) and Huatai Capital
Investment Limited
671,000 2.1% 0.4% 0.4% No
Total 13,420,400 42.5% 8.1% 8.1%
Notes:
(1) For further details of the Cornerstone Investors, please refer to the section headed “Cornerstone Investors ” in
the Prospectus.
(2) Taking into account the full exercise of the Offer Size Adjustment Option and before any exercise of the
Over-allotment Option.
(3) Erik Selin Fastigheter Aktiebolag ( “Erik Selin Fastigheter AB ”) is a substantial shareholder of Ribocure AB,
a subsidiary of the Company. Therefore, Erik Selin Fastigheter AB is a core connected person of the Company.
The Company has applied for, and the Stock Exchange has granted, a waiver from strict compliance with Rule
9.09(b) of the Listing Rules to permit Erik Selin Fastigheter AB to participate as a cornerstone investor in the
Global Offering. For details, please refer to the section headed “Waiver From Strict Compliance with the Listing
Rules and Exemption From Strict Compliance with the Companies (Winding Up and Miscellaneous Provisions)
Ordinance – Waiver From Strict Compliance with Rule 9.09(b) of the Listing Rules in relation to Cornerstone
Subscription by a Core Connected Person ” in the Prospectus.


--- page 7 ---
7
Allotees with Waivers/Consents Obtained
Investor
Number of
Offer Shares
allocated
% of Offer
Shares (1)
% of total
issued
H Shares
after
the Global
Offering (1)
% of total
issued share
capital after
the Global
Offering (1) Relationship
Allotees with consent under paragraph 1C(2) of the Placing Guidelines in relation to subscription for Offer Shares by existing Shareholders
and close associates of existing Shareholders (2)
William WONG ( ˮጳ਷) 402,600 1.27% 0.24% 0.24% An existing Shareholder
and a placee
Worldstar Global Holdings Limited 67,000 0.21% 0.04% 0.04% An existing Shareholder
and a placee
Blue Bay Healthcare Anchor Fund SPC 336,000 1.06% 0.20% 0.20% A close associate of an
existing Shareholder
and a placee
Allotees with consent under paragraph 1C(1) of the Placing Guidelines in relation to allocations to connected clients (2)
CICC Financial Trading Limited (in
connection with Zhonghe OTC
Swaps) (3)
671,000 2.12% 0.40% 0.40% Each is a connected client
of China International
Capital Corporation
Hong Kong Securities
Limited and a placeeCICC Financial Trading Limited (in
connection with Yongjin OTC
Swaps) (3)
40,000 0.13% 0.02% 0.02%
CICC Financial Trading Limited (in
connection with Minghong OTC
Swaps) (3)
13,400 0.04% 0.01% 0.01%
CICC Financial Trading Limited (in
connection with Wangzheng OTC
Swaps) (3)
1,200 0.00% 0.00% 0.00%
Notes:
(1) Taking into account the full exercise of the Offer Size Adjustment Option and before any exercise of the Over-
allotment Option.
(2) For details of (i) the consent under paragraph 1C(2) of the Placing Guidelines granted by the Stock Exchange to
permit the Company to allocate certain Offer Shares in the International Offering to close associates of existing
Shareholders, and (ii) the consent under paragraph 1C(1) of the Placing Guidelines in relation to allocations
to connected clients, please refer to the section headed “Waivers From Strict Compliance with the Listing
Rules and exemption from Strict Compliance with the Companies (Winding Up and Miscellaneous Provisions)
Ordinance ” in the Prospectus and the section headed “Other Information ” in this announcement.
(3) As defined in the section headed “Other Information – Placing to connected clients with prior consent under
paragraph 1C(1) of the Placing Guidelines ” in this announcement.


--- page 8 ---
8
Investor
Number of
Offer Shares
allocated
% of Offer
Shares (1)
% of total
issued
H Shares
after
the Global
Offering (1)
% of total
issued share
capital after
the Global
Offering (1) Relationship
Guotai Junan Investments (Hong Kong)
Limited
274,600 0.87% 0.17% 0.17% A connected client
of Guotai Junan
Securities (Hong
Kong) Limited
and HAITONG
INTERNATIONAL
SECURITIES
COMPANY
LIMITED, and a
placee
ABCI Asset Management Limited 5,800 0.02% 0.00% 0.00% A connected client of
ABCI Capital Limited
and ABCI Securities
Company Limited and
a placee
ICBC UBS Asset Management Co., Ltd. 94,000 0.30% 0.06% 0.06% Each is a connected client
of ICBC International
Securities Limited and
a placee
Invesco Great Wall Fund Management
Co., Ltd.
6,600 0.02% 0.00% 0.00%
Fullgoal Fund Management CO. LTD 100,600 0.32% 0.06% 0.06% Each is a connected
client of Guotai
Junan Securities
(Hong Kong) Limited
and HAITONG
INTERNATIONAL
SECURITIES
COMPANY
LIMITED, and a
placee
Fullgoal Asset management (HK)
Limited
100,600 0.32% 0.06% 0.06%
HAITONG INTERNATIONAL ASSET
MANAGEMENT (HK) LIMITED
6,600 0.02% 0.00% 0.00%


--- page 9 ---
9
LOCK-UP UNDERTAKINGS
Pre-IPO Investors (as defined in the “History and Corporate Structure ” section of the
Prospectus)
Name
Number of
shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon Listing (1)
Last day subject
to the lock-up
undertakings (2)
Future Industry Investment Fund
 (Limited Partnership)
 (ږ( Υྫ ))
11,430,002 11,430,002 6.89% 6.89% January 8, 2027
Ningbo Panlin Qianyuan Equity Investment
 Partnership (Limited Partnership)
 (ᛆҳ༟ΥྫΆุ (Υྫ ))
4,380,906 4,380,906 2.64% 2.64% January 8, 2027
Hangzhou Panlin Xukang Venture Capital
 Partnership (Limited Partnership)
 (ψᇂᎌϛੰ௴ุҳ༟ΥྫΆุ (Υྫ ))
1,175,724 1,175,724 0.71% 0.71% January 8, 2027
Jiaxing Panlin Guangci Venture Capital
 Partnership (Limited Partnership)
 ( ྗጳᇂᎌᄿฉ௴ุҳ༟ΥྫΆุ (Υྫ ))
1,004,334 1,004,334 0.61% 0.61% January 8, 2027
Jiaxing Panlin Yuesheng Venture Capital
 Partnership (Limited Partnership)
 (͛௴ุҳ༟ΥྫΆุ (Υྫ ))
817,455 817,455 0.49% 0.49% January 8, 2027
Shanghai Panlong Venture Capital Partnership
 (Limited Partnership)
 ( ɪऎᇂᗬ௴ุҳ༟ΥྫΆุ (Υྫ ))
817,455 817,455 0.49% 0.49% January 8, 2027
Qingdao Panlin Hongyu Venture Capital
 Partnership (Limited Partnership)
 (ᇂᎌᒿ༃௴ุҳ༟Άุ (Υྫ ))
782,695 782,695 0.47% 0.47% January 8, 2027
Wise Vigour Limited 8,714,881 8,714,881 5.26% 5.26% January 8, 2027
Kunshan Industrial Technology Research
 Institute of Small Nucleic Acid Biotechnology
 Research Institute Co. Ltd.
 (Ҧஔ
 ப΂ʮ̡ )
3,224,973 3,224,973 1.94% 1.94% January 8, 2027
Kunshan Hi-tech Venture Investment Co., Ltd.
 (ʮ̡ )
2,553,454 2,553,454 1.54% 1.54% January 8, 2027


--- page 10 ---
10
Name
Number of
shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon Listing (1)
Last day subject
to the lock-up
undertakings (2)
Kunshan Guoke Venture Capital Co., Ltd.
 (ʮ̡ )
1,877,862 1,877,862 1.13% 1.13% January 8, 2027
Kunshan Gongyan Venture Investment Co. Ltd.
 (ʮ̡ )
816,246 816,246 0.49% 0.49% January 8, 2027
Ionis Pharmaceuticals, Inc. 7,634,247 7,634,247 4.60% 4.60% January 8, 2027
Shenzhen Yilong Venture Capital L.P.
 ( ଉέᑈᎲ௴ุҳ༟ΥྫΆุ (Υྫ ))
6,297,338 6,297,338 3.80% 3.80% January 8, 2027
Suzhou Jiyuan Yuanxing Equity Investment L.P.
 (ᛆҳ༟ΥྫΆุ (Υྫ ))
5,239,889 5,239,889 3.16% 3.16% January 8, 2027
Tianjin Haihe Asymchem Biopharmaceutical
 Industry Innovation Investment L.P.
 (ږ
( Υྫ ))
1,949,716 1,949,716 1.18% 1.18% January 8, 2027
Trinity Zhongzhi (Tianjin) Venture Capital
 Center L.P.
 ( ɧɓ଺қ (ݵ)௴ุҳ༟ʕː (Υྫ ))
878,766 878,766 0.53% 0.53% January 8, 2027
Trinity Zhongzhi II (Tianjin) Venture Capital
 Center L.P.( ɧɓ଺қɚಂ (ݵ)௴ุҳ༟
 ʕː(Υྫ ))
537,055 537,055 0.32% 0.32% January 8, 2027
Trinity UCSF Limited 347,418 347,418 0.21% 0.21% January 8, 2027
TIF Biomedical Fund II VCC 358,036 358,036 0.22% 0.22% January 8, 2027
CICC Qide (Xiamen) Innovation Biomedical
 Venture Capital Partnership (Limited
 Partnership) (઼ᅃ (ژ)ᔼᖹ
 ௴ุҳ༟ΥྫΆุ (Υྫ ))
2,091,741 2,091,741 1.26% 1.26% January 8, 2027
Ningbo Meishan Bonded Port District Qirui
 Equity Investment L.P.
 (ᛆҳ༟ʕː
 (Υྫ ))
983,629 983,629 0.59% 0.59% January 8, 2027
China Resources Venture Investment Co., Ltd.
 (ʮ̡ )
2,133,099 2,133,099 1.29% 1.29% January 8, 2027


--- page 11 ---
11
Name
Number of
shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon Listing (1)
Last day subject
to the lock-up
undertakings (2)
Shanghai Yangtze River Delta Industrial
 Upgrading Equity Investment L.P.
 (ᛆҳ༟ΥྫΆุ
 (Υྫ ))
1,969,908 1,969,908 1.19% 1.19% January 8, 2027
Mr. LIU Guoping ( ᄎ਷̻) 1,899,525 1,899,525 1.15% 1.15% January 8, 2027
Jiaxing Futong Investment L.P.
 ( ྗጳ၅ஷҳ༟ΥྫΆุ (Υྫ ))
1,881,880 1,881,880 1.13% 1.13% January 8, 2027
Jinan Mingxin Industrial Investment Fund
 Partnership (Limited Partnership)
 (ΥྫΆุ (Υྫ ))
1,864,127 1,864,127 1.12% 1.12% January 8, 2027
Zhuhai Qiheng Equity Investment L.P.
 ( मऎ〾㛬ҳ༟ΥྫΆุ (Υྫ ))
1,852,159 1,852,159 1.12% 1.12% January 8, 2027
Wenzhou Chouqin Borui Venture Investment L.P.
 ( ๝ψཇා௹๿௴ุҳ༟ΥྫΆุ )
1,318,973 1,318,973 0.80% 0.80% January 8, 2027
Tianjin Chouqin Tiancheng Venture
 Investment L.P.
 (ཇා˂ϓ௴ุҳ༟ΥྫΆุ )
338,302 338,302 0.20% 0.20% January 8, 2027
Xizang Xingfan Enterprise Management Co., Ltd.
 (ʮ̡ )
687,302 687,302 0.41% 0.41% January 8, 2027
Wuxi Xingxi Venture Capital Partnership
 (Limited Partnership)
 (፼௴ุҳ༟ΥྫΆุ (Υྫ ))
867,471 867,471 0.52% 0.52% January 8, 2027
Jiaxing Co-way Yintian Venture Capital L.P.
 ( ྗጳ଺ිვ͞௴ุҳ༟ΥྫΆุ (Υྫ ))
1,045,869 1,045,869 0.63% 0.63% January 8, 2027
Jiaxing Xiangtian Venture Capital L.P.
 ( ྗጳ൥͞௴ุҳ༟ΥྫΆุ (Υྫ ))
367,026 367,026 0.22% 0.22% January 8, 2027
Ningbo Daxie Yungong Jiajie Equity Investment
 Partnership (Limited Partnership)
 (ᛆҳ༟ΥྫΆุ
 (Υྫ ))
1,367,837 1,367,837 0.82% 0.82% January 8, 2027


--- page 12 ---
12
Name
Number of
shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon Listing (1)
Last day subject
to the lock-up
undertakings (2)
Shanghai Zhulu Enterprise Management
 Consultation Center L.P.
 ( ɪऎጘ௔Άุ၍ଣፔ༔ʕː (Υྫ ))
1,181,943 1,181,943 0.71% 0.71% January 8, 2027
Zhuhai Qidi Rongchuang I Medical Industry
 Investment L.P.(ፄ௴ɓಂᔼᐕପุ
 ҳ༟ΥྫΆุ (Υྫ ))
1,026,853 1,026,853 0.62% 0.62% January 8, 2027
Zhuhai Rongqian Equity Investment L.P.
 (ΥྫΆุ (Υྫ ))
138,764 138,764 0.08% 0.08% January 8, 2027
Langma Twenty (Shenzhen) Venture Capital
 Center L.P.(ီɚɤ໮ (ଉέ)
 ௴ุҳ༟ʕː (Υྫ ))
197,573 197,573 0.12% 0.12% January 8, 2027
Langma Thirty-Two (Shenzhen) Venture Capital
 Center L.P.(ီɧɤɚ໮ (ଉέ)
 ௴ุҳ༟ʕː (Υྫ ))
136,075 136,075 0.08% 0.08% January 8, 2027
Langma Ninety-Five (Shenzhen) Private Equity
 Venture Investment Fund Partnership
 (Limited Partnership)(ီɘɤʞ໮ (ଉέ)
 ΥྫΆุ (Υྫ ))
561,687 561,687 0.34% 0.34% January 8, 2027
Langma Ninety-Six (Shenzhen) Private Equity
 Venture Investment Fund Partnership
 (Limited Partnership)(ီɘɤʬ໮ (ଉέ)
 ΥྫΆุ (Υྫ ))
240,723 240,723 0.15% 0.15% January 8, 2027
Mr. William Wong ( ˮጳ਷) 895,091 895,091 0.54% 0.54% January 8, 2027
Ningbo Boyuan Huizhi Enterprise Management
 Partnership (Limited Partnership)
 (௹Ⴣි౽Άุ၍ଣΥྫΆุ (Υྫ ))
848,299 848,299 0.51% 0.51% January 8, 2027
Rixir Therapeutics, Limited 816,246 816,246 0.49% 0.49% January 8, 2027
Zhuhai Hongtao Youxuan Equity Investment
 Partnership (LP)(ᛆҳ༟
 ΥྫΆุ (Υྫ ))
697,248 697,248 0.42% 0.42% January 8, 2027
Shenzhen Hongtao Jiaxin Equity Investment L.P
 (ᛆҳ༟ΥྫΆุ (Υྫ ))
90,716 90,716 0.05% 0.05% January 8, 2027
Mr. Claes Robert Wahlestedt 712,500 712,500 0.43% 0.43% January 8, 2027


--- page 13 ---
13
Name
Number of
shares held in
the Company
subject to
lock-up
undertakings
upon Listing
Number of H
Shares held in
the Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon Listing (1)
Last day subject
to the lock-up
undertakings (2)
Mr. Joseph Wade Collard 712,500 712,500 0.43% 0.43% January 8, 2027
Xinsu Ronghe (Changezhou) Environment
 Protection Investment Fund L.P.
 ( อᘽፄΥ (੬ψ)ږ( Υྫ ))
613,092 613,092 0.37% 0.37% January 8, 2027
Shenzhen Blue Ocean No. 1 Fund Management
 Investment Center L.P.
 (၍ଣҳ༟ʕː )
554,287 554,287 0.33% 0.33% January 8, 2027
Kunshan Shuangyu Investment Enterprise L.P.
 (ҳ༟Άุ (Υྫ ))
541,674 541,674 0.33% 0.33% January 8, 2027
Worldstar Global Holdings Limited 501,506 501,506 0.30% 0.30% January 8, 2027
Shenzhen Xinchuang Medical Private Equity
 Investment Fund Partnership (Limited
 Partnership)(ږ
 ΥྫΆุ (Υྫ ))
401,205 401,205 0.24% 0.24% January 8, 2027
Shanghai Bluestone Investment Co., Ltd.
 (ʮ̡ )
389,151 389,151 0.23% 0.23% January 8, 2027
Shanghai Chuang Yuan Yuan Investment
 Management Co. Ltd.
 (ʮ̡ )
382,268 382,268 0.23% 0.23% January 8, 2027
Yantai Muxin Biopharmaceutical Health Industry
 Development Partnership (Limited Partnership)
 (ΥྫΆุ
 (Υྫ ))
300,904 300,904 0.18% 0.18% January 8, 2027
Ms. CHEN Chi Nga ( ௓ʘඩ) 268,527 268,527 0.16% 0.16% January 8, 2027
Mr. LI Xiaofeng (ࢤ267,470 267,470 0.16% 0.16% January 8, 2027
Mr. MI Zhongye ( ᥙ΀ุ) 80,241 80,241 0.05% 0.05% January 8, 2027
Subtotal 94,063,843 94,063,843 56.73% 56.73%
Notes:
(1) Taking into account the full exercise of the Offer Size Adjustment Option and before any exercise of the Over-
allotment Option.
(2) The expiry date of the lock-up period shown in the table above is pursuant to the PRC Company Law.


--- page 14 ---
14
Existing Shareholders (other than the Pre-IPO Investors as defined in the “History and
Corporate Structure ” section of the Prospectus)
Name
Number
of shares
held in the
Company
subject to
lock-up
undertakings
upon Listing
Number of
H Shares
held in the
Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon
Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon
Listing (1)
Last day
subject to
the lock-up
undertakings (2)
Dr. LIANG Zicai ( ૑ɿʑ) 14,546,306 14,546,306 8.77% 8.77% January 8, 2027
Kunshan Ruikong Enterprise Management
 Consulting L.P.
 (ʆ๿છΆุ၍ଣፔ༔ΥྫΆุ (Υྫ ))
10,842,204 10,842,204 6.54% 6.54% January 8, 2027
Kunshan Ruiman Enterprise Management
 Consulting L.P.
 (ʆ๿ਟΆุ၍ଣፔ༔ΥྫΆุ (Υྫ ))
5,539,551 5,539,551 3.34% 3.34% January 8, 2027
Ms. MO Hua ( ୽ശ) 3,037,458 3,037,458 1.83% 1.83% January 8, 2027
Prof. XI Zhen (ॆ) 2,847,150 2,847,150 1.72% 1.72% January 8, 2027
Prof. ZHANG Lihe ( ੵᓿձ) 1,898,100 1,898,100 1.14% 1.14% January 8, 2027
Kunshan Ruiji Enterprise Management
 Consulting L.P.
 (ʆ๿ҦΆุ၍ଣፔ༔ΥྫΆุ (Υྫ ))
1,428,498 1,428,498 0.86% 0.86% January 8, 2027
Subtotal 40,139,267 40,139,267 24.21% 24.21%
Notes:
(1) Taking into account the full exercise of the Offer Size Adjustment Option and before any exercise of the Over-
allotment Option.
(2) The expiry date of the lock-up period shown in the table above is pursuant to the PRC Company Law.


--- page 15 ---
15
Cornerstone Investors
Name
Number
of shares
held in the
Company
subject to
lock-up
undertakings
upon Listing
Number of
H Shares
held in the
Company
subject to
lock-up
undertakings
upon Listing
% of total
issued H
Shares after
the Global
Offering
subject to
lock-up
undertakings
upon
Listing (1)
% of
shareholding
in the
Company
subject to
lock-up
undertakings
upon
Listing (1)
Last day
subject to
the lock-up
undertakings (2)
Arc Avenue Asset Management Pte. Ltd. 671,000 671,000 0.40% 0.40% July 8, 2026
Bright Stone Holdings Limited 536,800 536,800 0.32% 0.32% July 8, 2026
China Asset Management Co., Ltd. 2,013,200 2,013,200 1.21% 1.21% July 8, 2026
Da Cheng International Asset Management
 Company Limited and Dacheng Fund
 Management Company Limited
2,013,200 2,013,200 1.21% 1.21% July 8, 2026
Erik Selin Fastigheter Aktiebolag 1,342,000 1,342,000 0.81% 0.81% July 8, 2026
Himension Fund 1,342,000 1,342,000 0.81% 0.81% July 8, 2026
IvyRock Asset Management (HK) Limited 536,800 536,800 0.32% 0.32% July 8, 2026
Mingxin Growth Ventures LS2 Limited 1,342,000 1,342,000 0.81% 0.81% July 8, 2026
Springs Capital (Hong Kong) Limited 1,342,000 1,342,000 0.81% 0.81% July 8, 2026
Taikang Life Insurance Co., Ltd. 1,610,400 1,610,400 0.97% 0.97% July 8, 2026
Tenbagger Capital Nengxin), LP.
 (၍ଣΥྫΆุ
 (Υྫ )), Tenbagger Capital
 (Shanghai, Ziran), LP. (Ԏ
 ҳ༟၍ଣΥྫΆุ (Υྫ ))
 and Huatai Capital Investment Limited
671,000 671,000 0.40% 0.40% July 8, 2026
Subtotal 13,420,400 13,420,400 8.09% 8.09%
Notes:
(1) Taking into account the full exercise of the Offer Size Adjustment Option and before any exercise of the Over-
allotment Option.
(2) Each Cornerstone Investor shall not dispose of any of the Offer Shares acquired in the Global Offering at
any time during the period of six months following the Listing Date pursuant to their respective Cornerstone
Investment Agreement, save for certain limited circumstances, such as transfers to any of its wholly-owned
subsidiaries who will be bound by the same obligations of the relevant Cornerstone Investor, including the lock-
up period restriction. For details, please refer to the section headed “Cornerstone Investors – Restrictions on the
Cornerstone Investors ” of the Prospectus.


--- page 16 ---
16
PLACEE CONCENTRATION ANALYSIS
Placees
Number of
H Shares
Allocated
Allotment
as % of
International
Offering
(assuming no
exercise of the
Over-allotment
Option)
Allotment
as % of
International
Offering
(assuming
the Over-
allotment
Option is
exercised and
new H Shares
are issued)
Allotment as
% of total
Offer Shares
(assuming no
exercise of the
Over-allotment
Option)
Allotment as
% of total
Offer Shares
(assuming the
Over-allotment
Option is
exercised and
new H Shares
are issued)
Number of
Shares held
upon Listing
% of total
issued share
capital upon
Listing
(assuming no
exercise of the
Over-allotment
Option)
% of total
issued share
capital upon
Listing
(assuming the
Over-allotment
Option is
exercised and
new H Shares
are issued)
Top 1 2,013,200 6.98% 5.99% 6.37% 5.54% 2,013,200 1.21% 1.18%
Top 5 7,958,000 27.57% 23.68% 25.18% 21.89% 7,958,000 4.80% 4.67%
Top 10 14,507,200 50.26% 43.17% 45.89% 39.91% 14,507,200 8.75% 8.51%
Top 25 23,153,200 80.22% 68.90% 73.25% 63.69% 23,153,200 13.96% 13.58%
Notes
* Ranking of placees is based on the number of H Shares allotted to the placees.
H SHAREHOLDERS CONCENTRATION ANALYSIS
H Shareholders*
Number of
H Shares
allotted
Allotment
as % of
International
Offering
(assuming
no exercise
of the Over-
allotment
Option)
Allotment
as % of
International
Offering
(assuming
the Over-
allotment
Option is
exercised
and new H
Shares are
issued)
Allotment
as % of
total Offer
Shares
(assuming
no exercise
of the
Over-
allotment
Option)
Allotment
as % of
total Offer
Shares
(assuming
the Over-
allotment
Option is
exercised
and new H
Shares are
issued)
Number of
H Shares
held upon
Listing
% of total
issued H
Shares
capital upon
Listing
(assuming
no exercise
of the Over-
allotment
Option)
% of total
issued H
Shares
capital upon
Listing
assuming
the Over-
allotment
Option is
exercised
and new H
Shares are
issued)
Number of
Shares held
upon Listing
Top 1 0 0.00% 0.00% 0.00% 0.00% 40,139,267 24.21% 23.53% 40,139,267
Top 5 0 0.00% 0.00% 0.00% 0.00% 79,215,817 47.77% 46.45% 79,215,817
Top 10 0 0.00% 0.00% 0.00% 0.00% 105,533,652 63.65% 61.88% 105,533,652
Top 25 9,662,800 28.83% 24.76% 30.57% 26.58% 131,235,157 79.15% 76.95% 131,235,157
Notes
* Ranking of H Shareholders is based on the number of H Shares held by the H Shareholders upon Listing.


--- page 17 ---
17
SHAREHOLDER CONCENTRATION ANALYSIS
Shareholders
Number of
H Shares
allotted
Allotment
as % of
International
Offering
(assuming
no exercise
of the Over-
allotment
Option)
Allotment
as % of
International
Offering
(assuming
the Over-
allotment
Option is
exercised
and new
H Shares
are issued)
Allotment
as % of
total Offer
Shares
(assuming
no exercise
of the
Over-
allotment
Option)
Allotment
as % of
total Offer
Shares
(assuming
the Over-
allotment
Option is
exercised
and new
H Shares
are issued)
Number of
H Shares
held upon
Listing
Number of
Share held
upon
Listing
% of total
issued share
capital upon
Listing
(assuming
no exercise
of the
Over-
allotment
Option)
% of total
issued share
capital upon
Listing
(assuming
the Over-
allotment
Option is
exercised
and new
H Shares
are issued)
Top 1 0 0.00% 0.00% 0.00% 0.00% 40,139,267 40,139,267 24.21% 23.53%
Top 5 0 0.00% 0.00% 0.00% 0.00% 79,215,817 79,215,817 47.77% 46.45%
Top 10 0 0.00% 0.00% 0.00% 0.00% 105,533,652 105,533,652 63.65% 61.88%
Top 25 9,662,800 28.83% 24.76% 30.57% 26.58% 131,235,157 131,235,157 79.15% 76.95%
Notes
* Ranking of Shareholders is based on the number of Shares (of all classes) held by the Shareholder upon Listing.


--- page 18 ---
18
BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
Subject to the satisfaction of the conditions set out in the Prospectus, a total of 42,771 valid
applications made by the public will be conditionally allocated on the basis set out below:
NO. OF
SHARES
APPLIED FOR
NO. OF
VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
 PERCENTAGE
ALLOTTED OF
THE TOTAL
NO. OF SHARES
 APPLIED FOR
POOL A
200 26,796 457 out of 26,796 to receive 200 Shares 1.71%
400 2,121 72 out of 2,121 to receive 200 Shares 1.70%
600 1,068 54 out of 1,068 to receive 200 Shares 1.69%
800 3,408 227 out of 3,408 to receive 200 Shares 1.67%
1,000 749 62 out of 749 to receive 200 Shares 1.66%
1,200 211 21 out of 211 to receive 200 Shares 1.66%
1,400 175 20 out of 175 to receive 200 Shares 1.63%
1,600 434 56 out of 434 to receive 200 Shares 1.61%
1,800 344 50 out of 344 to receive 200 Shares 1.61%
2,000 1,897 304 out of 1,897 to receive 200 Shares 1.60%
3,000 586 141 out of 586 to receive 200 Shares 1.60%
4,000 481 154 out of 481 to receive 200 Shares 1.60%


--- page 19 ---
19
NO. OF
SHARES
APPLIED FOR
NO. OF
VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
 PERCENTAGE
ALLOTTED OF
THE TOTAL
NO. OF SHARES
 APPLIED FOR
POOL A
5,000 319 127 out of 319 to receive 200 Shares 1.59%
6,000 304 145 out of 304 to receive 200 Shares 1.59%
7,000 180 100 out of 180 to receive 200 Shares 1.59%
8,000 212 135 out of 212 to receive 200 Shares 1.59%
9,000 142 101 out of 142 to receive 200 Shares 1.58%
10,000 978 775 out of 978 to receive 200 Shares 1.58%
20,000 680 200 Shares plus 397 out of 680 to receive
additional 200 Shares
1.58%
30,000 234 400 Shares plus 88 out of 234 to receive
additional 200 Shares
1.58%
40,000 156 600 Shares plus 21 out of 156 to receive
additional 200 Shares
1.57%
50,000 120 600 Shares plus 110 out of 120 to receive
additional 200 Shares
1.57%
60,000 93 800 Shares plus 65 out of 93 to receive
additional 200 Shares
1.57%
70,000 53 1,000 Shares plus 26 out of 53 to receive
additional 200 Shares
1.57%
80,000 88 1,200 Shares plus 23 out of 88 to receive
additional 200 Shares
1.57%
41,829 Total number of Pool A successful
applicants: 4,425
POOL B
90,000 466 600 Shares plus 106 out of 466 to receive
additional 200 Shares
0.72%
100,000 151 600 Shares plus 89 out of 151 to receive
additional 200 Shares
0.72%
150,000 87 1,000 Shares plus 33 out of 87 to receive
additional 200 Shares
0.72%
200,000 73 1,400 Shares plus 13 out of 73 to receive
additional 200 Shares
0.72%
250,000 34 1,600 Shares plus 33 out of 34 to receive
additional 200 Shares
0.72%
300,000 18 2,000 Shares plus 14 out of 18 to receive
additional 200 Shares
0.72%


--- page 20 ---
20
NO. OF
SHARES
APPLIED FOR
NO. OF
VALID
APPLICATIONS BASIS OF ALLOTMENT/BALLOT
APPROXIMATE
 PERCENTAGE
ALLOTTED OF
THE TOTAL
NO. OF SHARES
 APPLIED FOR
POOL B
350,000 11 2,400 Shares plus 6 out of 11 to receive
additional 200 Shares
0.72%
400,000 21 2,800 Shares plus 7 out of 21 to receive
additional 200 Shares
0.72%
500,000 13 3,400 Shares plus 12 out of 13 to receive
additional 200 Shares
0.72%
600,000 6 4,200 Shares plus 3 out of 6 to receive
additional 200 Shares
0.72%
700,000 9 5,000 Shares plus 1 out of 9 to receive
additional 200 Shares
0.72%
800,000 6 5,600 Shares plus 4 out of 6 to receive
additional 200 Shares
0.72%
900,000 2 6,400 Shares plus 1 out of 2 to receive
additional 200 Shares
0.72%
1,000,000 11 7,000 Shares plus 10 out of 11 to receive
additional 200 Shares
0.72%
1,374,400 34 9,800 Shares plus 10 out of 34 to receive
additional 200 Shares
0.72%
942 Total number of Pool B successful
applicants: 942
As of the date of this announcement, the relevant subscription monies previously deposited in the
designated nominee accounts have been remitted back to the accounts of all HKSCC participants.
Investors should contact their relevant brokers for any inquiries.
COMPLIANCE WITH LISTING RULES AND GUIDANCE
The Directors confirm that, except for the Listing Rules that have been waived and/or in respect of
which consent has been obtained, the Company has complied with the Listing Rules and guidance
materials in relation to the placing, allotment and listing of the Company ’s H Shares.
The Directors confirm that, to the best of their knowledge, no rebate has been, directly or
indirectly, provided by the Company, its controlling shareholder(s), directors or syndicate members
to any placees or the public (as the case may be) and the consideration payable by them for each
Offer Share of the Company subscribed for or purchased by them is the same as the Offer Price
determined by the Company, in addition to any brokerage, AFRC transaction levy, SFC transaction
levy and trading fee payable.


--- page 21 ---
21
OTHER INFORMATION
Offer Size Adjustment Option
The Offer Size Adjustment Option has been fully exercised by the Overall Coordinators, pursuant
to which the Company is issuing and allotting 4,123,000 additional Offer Shares, representing
approximately 15% of the total number of Offer Shares initially available under the Global
Offering, at the Offer Price. All of the additional Offer Shares that would be allotted and issued by
the Company pursuant to the full exercise of the Offer Size Adjustment Option will be allocated
to the International Offering. Accordingly, the total number of Offer Shares finally available under
the Global Offering (taking into account the full exercise of the Offer Size Adjustment Option
and before any exercise of the Over-allotment Option) that would be allotted and issued by the
Company is 31,610,400 Offer Shares and the total issued share capital of the Company upon
Listing (taking into account the full exercise of the Offer Size Adjustment Option and before any
exercise of the Over-allotment Option) will be 165,813,510 Shares.
As a result of the above, the final number of Offer Shares under the International Offering is
adjusted to 28,861,600 Shares, representing approximately 91.3% of the total number of Offer
Shares under the Global Offering (assuming the Over-allotment Option is not exercised).
Placing to existing Shareholders and/or their close associates with prior consent under
paragraph 1C(2) of the Placing Guidelines
Mr. Wong and Worldstar Global (collectively, the “Existing Shareholders as Placees ”), and
Blue Bay (the “Close Associate of Existing Shareholders as Placee ”)
The Company has applied to the Stock Exchange, and the Stock Exchange has granted a consent
under paragraph 1C(2) of the Placing Guidelines to permit the Company to allocate such Offer
Shares in the International Offering to the Existing Shareholders as Placees and the Close
Associate of Existing Shareholders as Placee set out below:
(1) Mr. William WONG ( ˮጳ਷) (“Mr. Wong ”), an existing Shareholder of the Company.
(2) Worldstar Global Holdings Limited ( “Worldstar Global ”), an existing Shareholder of the
Company.
(3) Blue Bay Healthcare Anchor Fund SPC ( “Blue Bay ”) is a close associate of Shenzhen Blue
Ocean No. 1 Fund Management Investment Center L.P. (၍ଣҳ༟ʕː (Ϟ
Υྫ)) ( “Blue Ocean Investment ”), an existing Shareholder of the Company.
The allocation of Offer Shares to the Existing Shareholders as Placees and the Close Associate of
Existing Shareholders as Placee is in compliance with all the conditions under the consent granted
by the Stock Exchange, including but not limited to (i) the Company complies with Rules 19A.13A
and 19A.13C of the Listing Rules, and (ii) no preference in allocation was given to the Existing
Shareholders as Placees and the Close Associate of Existing Shareholders as Placee.
For details of the allocations of Offer Shares to close associates of existing Shareholders, please
refer to the section headed “Allotment Results Details  – International Offering  – Allotees with
Waivers/Consents Obtained ” in this announcement.


--- page 22 ---
22
Placing to connected clients with prior consent under paragraph 1C(1) of the Placing
Guidelines
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted a
consent under paragraph 1C(1) of the Placing Guidelines to permit Tenbagger Nengxin, Tenbagger
Ziran and Huatai Capital Investment Limited (in connection with Huatai OTC Swaps) to participate
in the Global Offering as a cornerstone investor.
In addition, the Company has applied to the Stock Exchange, and the Stock Exchange has granted,
a consent under paragraph 1C(1) of the Placing Guidelines to permit the Company to allocate
certain Offer Shares in the International Offering to connected clients as placees. The allocation of
Offer Shares to such connected clients is in compliance with all the conditions under the consent
granted by the Stock Exchange.


--- page 23 ---
23
Details of the placement to the connected clients above are set out below.
No.
Name of connected
client
Name of connected
distributor
Relationship with the
connected distributor
Basis of
holding
securities
Number
of Offer
Shares
subscribed
Ultimate
beneficial
owner of
the Offer
Shares
allocated
to the
connected
client
Percentage
of the
Offer
Shares
subscribed
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into
account
full
exercise
of the
offer size
adjustment
option)
Percentage
of the
issued
Shares
of the
Company
immediately
upon
completion
of the
Global
Offering
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into account
full exercise
of the
offer size
adjustment
option)
1. CICC Financial
Trading Limited
(“CICC FT ”)
See Note 1 for further
information of the
ultimate clients of
CICC FT.
China International
Capital Corporation
Hong Kong Securities
Limited ( “CICC”)
CICC FT is a member
of the same group as
CICC.
Non-
discretionary
basis
725,600 See Note 1 2.30% 0.44%


--- page 24 ---
24
No.
Name of connected
client
Name of connected
distributor
Relationship with the
connected distributor
Basis of
holding
securities
Number
of Offer
Shares
subscribed
Ultimate
beneficial
owner of
the Offer
Shares
allocated
to the
connected
client
Percentage
of the
Offer
Shares
subscribed
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into
account
full
exercise
of the
offer size
adjustment
option)
Percentage
of the
issued
Shares
of the
Company
immediately
upon
completion
of the
Global
Offering
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into account
full exercise
of the
offer size
adjustment
option)
2. Guotai Junan
Investments (Hong
Kong) Limited
(“GTJAI”)
* Fullgoal Fund,
Fullgoal HK and
Haitong IAM (each
as defined below);
for their allocation
information, see
No. 6, No. 7 and
No. 8 in this table.
See Note 2 for further
information of the
ultimate clients of
GTJAI.
Guotai Junan Securities
(Hong Kong) Limited
(“GTJAS ”)
GTJAI, together with
Fullgoal Fund and
Fullgoal HK, are
members of the same
group as GTJAS and
Haitong International
(as defined below).
Non-
discretionary
basis
274,600 See Note 2
 and
 Note 5
0.87% 0.17%
3. ABCI Asset
Management
Limited ( “ABCI
AM”)
ABCI Capital Limited
and ABCI Securities
Company Limited
(“ABCI”)
ABCI AM is a member
of the same group as
ABCI.
Discretionary
basis
5,800 See Note 4 0.00% 0.00%


--- page 25 ---
25
No.
Name of connected
client
Name of connected
distributor
Relationship with the
connected distributor
Basis of
holding
securities
Number
of Offer
Shares
subscribed
Ultimate
beneficial
owner of
the Offer
Shares
allocated
to the
connected
client
Percentage
of the
Offer
Shares
subscribed
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into
account
full
exercise
of the
offer size
adjustment
option)
Percentage
of the
issued
Shares
of the
Company
immediately
upon
completion
of the
Global
Offering
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into account
full exercise
of the
offer size
adjustment
option)
4. ICBC UBS Asset
Management
Co., Ltd. ( “ICBC
UBS”)
ICBC International
Securities Limited
(“ICBCI”)
ICBC UBS and Invesco
are members of
the same group as
ICBCI.
Discretionary
basis
94,000 See Note 4 0.30% 0.06%
5. Invesco Great Wall
Fund Management
Co., Ltd.
(“Invesco ”)
Discretionary
basis
6,600 0.02% 0.00%
6. Fullgoal Fund
Management CO.
LTD ( “Fullgoal
Fund”)
HAITONG
INTERNATIONAL
SECURITIES
COMPANY
LIMITED ( “Haitong
International ”)
Fullgoal Fund, Fullgoal
HK and Haitong
IAM, together with
GTJAI, are members
of the same group as
GTJAS and Haitong
International.
Discretionary
basis
100,600 See Note 2
 and
 Note 5
0.32% 0.06%
7. Fullgoal Asset
management (HK)
Limited ( “Fullgoal
HK”)
Discretionary
basis
100,600 0.32% 0.06%


--- page 26 ---
26
No.
Name of connected
client
Name of connected
distributor
Relationship with the
connected distributor
Basis of
holding
securities
Number
of Offer
Shares
subscribed
Ultimate
beneficial
owner of
the Offer
Shares
allocated
to the
connected
client
Percentage
of the
Offer
Shares
subscribed
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into
account
full
exercise
of the
offer size
adjustment
option)
Percentage
of the
issued
Shares
of the
Company
immediately
upon
completion
of the
Global
Offering
(assuming
the Over-
allotment
Option
is not
exercised
and taking
into account
full exercise
of the
offer size
adjustment
option)
8. HAITONG
INTERNATIONAL
ASSET
MANAGEMENT
(HK) LIMITED
(“Haitong IAM ”)
* GTJAI; for
its allocation
information, see
No. 2 in this table.
Discretionary
basis
6,600 0.02% 0.00%
Notes:
1. CICC FT and China International Capital Corporation Limited ( “CICCL ”) will enter into a series of cross
border delta-one OTC swap transactions (collectively, the “Zhonghe OTC Swaps ”) with each other and the
ultimate clients (the “CICC FT Ultimate Clients (Zhonghe) ”), pursuant to which CICC FT will hold the Offer
Shares on a non-discretionary basis to hedge the Zhonghe OTC Swaps while the economic risks and returns of
the underlying Offer Shares are passed to the CICC FT Ultimate Clients (Zhonghe), subject to customary fees
and commissions. The Zhonghe OTC Swaps will be fully funded by the CICC FT Ultimate Clients (Zhonghe).
To the best of CICC FT ’s knowledge having made all reasonable inquiries, each of the CICC FT Ultimate
Clients (Zhonghe) is an independent third party of CICC FT, CICC and the companies which are members of
the same group of CICC, and the ultimate beneficial owner holding 30% or more interests in the of the CICC
FT Ultimate Clients (Zhonghe) is Zhang Jingting (ࢬ.)


--- page 27 ---
27
CICC FT and CICCL will enter into a series of cross border delta-one OTC swap transactions (collectively, the
“Yongjin OTC Swaps ”) with each other and the ultimate clients (the “CICC FT Ultimate Client (Yongjin) ”),
pursuant to which CICC FT will hold the Offer Shares on a non-discretionary basis to hedge the Yongjin OTC
Swaps while the economic risks and returns of the underlying Offer Shares are passed to the CICC FT Ultimate
Client (Yongjin), subject to customary fees and commissions. The Yongjin OTC Swaps will be fully funded
by the CICC FT Ultimate Client (Yongjin). To the best of CICC FT ’s knowledge having made all reasonable
inquiries, the CICC FT Ultimate Client (Yongjin) is an independent third party of CICC FT, CICC and the
companies which are members of the same group of CICC, and the ultimate beneficial owners holding 30%
or more interests in each of the of the CICC FT Ultimate Clients (Yongjin) are Wu Jialin (ᘅ) and Xie
Xiaoyong (ۇrespectively.
CICC FT and CICCL will enter into a series of cross border delta-one OTC swap transactions (collectively,
the “Minghong OTC Swaps ”) with each other and the ultimate clients (the “CICC FT Ultimate Client
(Minghong) ”), pursuant to which CICC FT will hold the Offer Shares on a non-discretionary basis to hedge the
Minghong OTC Swaps while the economic risks and returns of the underlying Offer Shares are passed to the
CICC FT Ultimate Client (Minghong), subject to customary fees and commissions. The Minghong OTC Swaps
will be fully funded by the CICC FT Ultimate Client (Minghong). To the best of CICC FT ’s knowledge having
made all reasonable inquiries, the CICC FT Ultimate Client (Minghong) is an independent third party of CICC
FT, CICC and the companies which are members of the same group of CICC, and no single ultimate beneficial
owner holds 30% or more interest in each of the CICC FT Ultimate Client (Minghong).
CICC FT and CICCL will enter into a series of cross border delta-one OTC swap transactions (collectively,
the “Wangzheng OTC Swaps ”) with each other and the ultimate clients (the “CICC FT Ultimate Client
(Wangzheng) ”), pursuant to which CICC FT will hold the Offer Shares on a non-discretionary basis to hedge
the Wangzheng OTC Swaps while the economic risks and returns of the underlying Offer Shares are passed to
the CICC FT Ultimate Client (Wangzheng), subject to customary fees and commissions. The Wangzheng OTC
Swaps will be fully funded by the CICC FT Ultimate Client (Wangzheng). To the best of CICC FT ’s knowledge
having made all reasonable inquiries, the CICC FT Ultimate Client (Wangzheng) is an independent third
party of CICC FT, CICC and the companies which are members of the same group of CICC, and the ultimate
beneficial owner holding 30% or more interests in the of the CICC FT Ultimate Clients (Wangzheng) is Zhai
Qin ( ᓻೞ).
2. It is proposed that Guotai Junan Investments (Hong Kong) Limited ( “GTJAI ”) participates as placee to
subscribe for the Offer Shares under the International Offering (the “GTJAI Subscription ”). GTJAI is a
member of the same group of companies as Guotai Junan Securities (Hong Kong) Limited ( “GTJAS”) and is
considered as a connected client of GTJAS pursuant to paragraph 1B(7) of the Placing Guidelines.
In relation to the GTJAI Subscription, GTJAI shall hold the Offer Shares for hedging purpose as the single
underlying asset of several sets of back-to-back total return swap transaction (the “GTHT Back-to-back TRS ”)
to be entered into between GTJAI and Guotai Haitong Securities Co., Ltd. (the “GTHT Onshore Parent ”)
in connection with several total return swap orders (the “GTHT Client TRS ”) to be entered into by GTHT
Onshore Parent and several ultimate clients (the “GTHT Onshore Ultimate Client ”), respectively. Such GTHT
Client TRS is to be fully funded by the GTHT Onshore Ultimate Client. GTJAI will hold the Offer Shares on
a non-discretionary basis for the purpose of hedging the economic exposure under the GTHT Back-to-back
TRS and GTHT Client TRS only, During the tenor of the GTHT Client TRS, all economic returns of the Offer
Shares will be passed to the GTHT Onshore Ultimate Clients and all economic losses shall be borne by the
GTHT Onshore Ultimate Client, subject to the terms and conditions of the GTHT Back-to-back TRS and GTHT
Client TRS, and GTJAI will not take part in any economic return or bear any economic loss in relation to the
price of the Offer Shares. The GTHT Onshore Ultimate Client may request to redeem the Offer Shares at their
own discretion, upon which GTJAI shall dispose of the Offer Shares and settle the GTHT Back-to-back TRS
and GTHT Client TRS in cash in accordance with the terms and conditions of the GTHT Back-to-back TRS and
GTHT Client TRS documents. Due to its internal policy, GTJAI will not exercise the voting right attaching to
the Offer Shares during the tenor of the GTHT Back-to-back TRS and GTHT Client TRS.


--- page 28 ---
28
To the best knowledge, information and belief of GTJAI after due enquiry, the GTHT Onshore Ultimate Clients
and their respective ultimate beneficial owners holding 30% or more interest include:
(i) Huang Shilin ( ර˰ᎌ);
(ii) Wang Jing ( ˮ᎑);
(iii) Sun Yuan (Ⴣ);
(iv) Chuxin Li ( ҽ̈อ);
(v) Yukai Shao (ρක);
(vi) Wu Jiaqi (ᘅ);
(vii) Xie Xiaoyong (ۇ;)
viii) Zeng Xiaojie ( ಀወᆎ);
(ix) ZHUANG TAO ( ୿ᏹ);
(x) CHEN QIN;
(xi) CUI TONGKUI ( ੦Νჺ);
(xii) XIAO MING (׼and
(xiii) Guo Kai ( ெ㷞).
To the best knowledge of GTJAI after making all reasonable enquiries, (i) GTJAI has confirmed that, to the best
of its knowledge, each of the GTHT Onshore Ultimate Clients and the ultimate beneficial owners holding 30%
or more interest of the GTHT Onshore Ultimate Clients listed above is an independent third party of GTJAI,
GTJAS and the companies which are members of the same group of companies as GTJAS, and (ii) GTJAI is not
a collective investment scheme which is not authorised by the SFC nor is expected to hold the Offer Shares on
behalf of such scheme.
3. ABCI AM intends to hold the Offer Shares in its capacity as manager managing investment portfolios on behalf
of underlying investors who are independent third parties on a discretionary basis.
4. ICBC UBS intends to hold the Offer Shares in its capacity as manager managing investment portfolios on behalf
of underlying investors who are independent third parties on a discretionary basis.
Invesco intends to hold the Offer Shares in its capacity as manager managing investment portfolios on behalf of
underlying investors who are independent third parties on a discretionary basis.
5. Fullgoal Fund intends to hold the Offer Shares in its capacity as manager managing investment portfolios on
behalf of underlying investors who are independent third parties on a discretionary basis.
Fullgoal HK intends to hold the Offer Shares in its capacity as manager managing investment portfolios on
behalf of underlying investors who are independent third parties on a discretionary basis.
Haitong IAM intends to hold the Offer Shares in its capacity as manager managing investment portfolios on
behalf of underlying investors who are independent third parties on a discretionary basis.


--- page 29 ---
29
DISCLAIMERS
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the
“Stock Exchange ”) and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no
responsibility for the contents of this announcement, make no representation as to its accuracy
or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising
from or in reliance upon the whole or any part of the contents of this announcement.
This announcement is not for release, publication, distribution, directly or indirectly, in or into
the United States (including its territories and possessions, any state of the United States and
the District of Columbia). This announcement does not constitute or form a part of any offer or
solicitation to purchase or subscribe for securities in the United States. The securities mentioned
herein have not been, and will not be, registered under the United States Securities Act of 1933,
as amended (the “U.S. Securities Act ”). The securities may not be offered or sold in the United
States except pursuant to an exemption from the registration requirements of the U.S. Securities
Act and in compliance with any applicable state securities laws, or outside the United States
unless in compliance with Regulation S under the U.S. Securities Act. There will be no public
offer of securities in the United States.
The Offer Shares are being offered and sold (1) solely to qualified institutional buyers as defined
in Rule 144A under the U.S. Securities Act pursuant to an exemption from registration under
the U.S. Securities Act and (2) outside the United States in offshore transactions in reliance on
Regulation S under the U.S. Securities Act.
This announcement is for information purposes only and does not constitute an invitation or
offer to acquire, purchase or subscribe for securities. This announcement is not a prospectus.
Potential investors should read the Prospectus dated December 31, 2025 issued by Suzhou Ribo
Life Science Co., Ltd. for detailed information about the Global Offering described below before
deciding whether or not to invest in the H Shares thereby being offered.
* Potential investors of the Offer Shares should note that the Joint Sponsors and the Overall
Coordinators (for themselves and on behalf of the Hong Kong Underwriters) shall be entitled
to terminate their obligations under the Hong Kong Underwriting Agreement with immediate
effect upon the occurrence of any of the events set out in the paragraph headed “Underwriting
– Underwriting Arrangements and Expenses – Hong Kong Public Offering –  Grounds for
Termination ” in the Prospectus at any time prior to 8:00 a.m. (Hong Kong time) on the Listing
Date (which is currently expected to be on January 9, 2026).
PUBLIC FLOAT AND FREE FLOAT
Immediately after the completion of the Global Offering, 110,900,415 H Shares, representing
approximately 66.88% of the issued share capital of our Company (before any exercise of the
Over-allotment Option) will count towards the public float. Therefore, the number of H shares held
in public hands is higher than the prescribed percentage of H Shares required to be held in public
hands under Rule 19A.13A(1) of the Listing Rules, satisfying the minimum percentage requirement
in compliance with Rule 19A.13A(1) of the Listing Rules, representing 15.61% of H Shares to be
held in public hands with the expected market value of HK$1.5 billion at the time of Listing, based
on the Offer Price of HK$57.97 per H Share.


--- page 30 ---
30
All the existing shareholders of the Company are subject to a lock-up period of 12 months
following the Listing Date pursuant to the applicable PRC laws and all the cornerstone investors
are subject to a lock-up period of six months following the Listing Date. The Offer Shares to be
subscribed by all the other investors participating in the Global Offering are not subject to any
disposal restriction. Excluding the Offer Shares to be allocated to the cornerstone investors that
are subject to a lock-up period of six months following the Listing Date, the Company ’s H Shares
to be counted towards the free float upon Listing will be 18,190,000 Shares. Based on the Offer
Price of HK$57.97 per H Share, the Company will satisfy the free float requirement under Rule
19A.13C(1)(b) of the Listing Rules
The Directors confirm that, immediately following completion of the Global Offering: (i) the
Shares will be held by at least 300 Shareholders at the time of Listing, in compliance with Rule
8.08(2) of the Listing Rules; (ii) the three largest public Shareholders will not hold more than
50% of the H Shares held in public hands at the time of Listing, in compliance with Rules 8.08(3)
and 8.24 of the Listing Rules; (iii) no placee will, individually, be placed more than 10% of the
enlarged issued share capital of the Company immediately after the Global Offering; and (iv) there
will not be any new substantial Shareholder (as defined in the Listing Rules) immediately after the
Global Offering.
COMMENCEMENT OF DEALINGS
The H Share certificates will only become valid evidence of title at 8:00 a.m. (Hong Kong time)
on Friday, January 9, 2026, provided that (i) the Global Offering has become unconditional in
all respects, and (ii) the right of termination described in the section headed “Underwriting  –
Underwriting Arrangements and Expenses  – Hong Kong Underwriting Agreement  – Grounds for
termination ” in the Prospectus has not been exercised. Investors who trade H Shares prior to the
receipt of H Share certificates or the H Share certificates becoming valid evidence of title do so
entirely at their own risk.
Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. (Hong Kong time)
on Friday, January 9, 2026,, it is expected that dealings in the H Shares on the Stock Exchange
will commence at 9:00 a.m. on Friday, January 9, 2026,. The H Shares will be traded in board lots
of 200 H Shares each and the stock code of the H Shares will be 6938.
By order of the Board
Suzhou Ribo Life Science Co., Ltd.
Dr. LIANG Zicai
Chairman, Executive Director and Chief Executive Officer
Hong Kong, January 8, 2026
Directors of the Company named in the application to which this announcement relates are Dr.
LIANG Zicai, Dr. GAN Liming and Dr. ZHANG Hongyan as executive directors, Dr. QI Fei,
Mr. LI Dongfang and Mr. LI Yuhui as non-executive directors, and Dr. YU Xuefeng, Mr. MA
Chaosong and Mr. WANG Ruiping as independent non-executive directors.